Quince Therapeutics, Inc. (QNCX)
NASDAQ: QNCX · Real-Time Price · USD
17.86
-0.43 (-2.32%)
At close: Jul 24, 2026, 4:00 PM EDT
17.75
-0.11 (-0.59%)
After-hours: Jul 24, 2026, 7:22 PM EDT
Quince Therapeutics Market Cap
Quince Therapeutics has a market cap or net worth of $17.46 million as of July 24, 2026. Its market cap has decreased by -79.35% in one year.
Market Cap
17.46M
Enterprise Value
17.46K
1-Year Change
-79.35%
Ranking
Category
Stock Price
$17.86
ChartMarket Cap Chart
Since May 9, 2019, Quince Therapeutics's market cap has decreased from $855.57M to $17.46M, a decrease of -97.96%. That is a compound annual growth rate of -41.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 17.46M | -90.64% |
| Dec 31, 2025 | 186.53M | 126.70% |
| Dec 31, 2024 | 82.28M | 82.80% |
| Dec 29, 2023 | 45.01M | 95.46% |
| Dec 30, 2022 | 23.03M | -93.89% |
| Dec 31, 2021 | 377.06M | -53.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Allarity Therapeutics | 19.41M |
| Pluri | 19.37M |
| Lisata Therapeutics | 19.31M |
| Longeveron | 19.19M |
| Daré Bioscience | 18.87M |
| Tevogen Bio Holdings | 18.61M |
| Quantum BioPharma | 18.16M |
| Lipocine | 18.05M |